Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years

JAMA

Volumn 276, Issue 22, 1996, Pages 1805-1810

  Schendel, Diana E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CEREBRAL PALSY; CHILD; CHILD DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECLAMPSIA; FEMALE; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEWBORN; PREECLAMPSIA; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RISK; UNITED STATES; VERY LOW BIRTH WEIGHT;

EID: 0029902517     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.22.1805     Document Type: Article

References (36)

1. Stanley FJ, Watson L. Trends in perinatal mortality and cerebral palsy in Western Australia, 1967 to 1985. BMJ. 1992;304:1658-1663.
2. Cummins SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr. 1993;123:230-237.
3. Rantakallio P, von Wendt L. Prognosis for low-birthweight infants up to the age of 14: a population study. Dev Sled Child Neural. 1985;27:655-663.
4. Mervis CA, Decoufle P, Murphy CC, Yeargin-Allsopp M. Low birthweight and the risk for mental retardation later in childhood. Paedlatr Perinat Epidemiol. 1995;9:455-468.
5. Bhushan V, Paneth N, Kiely JL. Impact of improved survival of very low birthweight infants on recent secular trends in the prevalence of cerebral palsy. Pediatrics. 1993;91:1094-1100.
6. Cooke RWI. Cerebral palsy in very low birth weight infants. Arch Dis Child. 1990;65:201-206.
7. Graziani LJ, Pasto M, Stanley C, et al. Neonatal neurosonographic correlates of cerebral palsy in preterm infants. Pediatrics. 1986;78:88-95.
8. de L Costello AM, Hamilton PA, Baudin J, et al. Prediction of neurodevelopmental impairment at four years from brain ultrasound appearance of very preterm infants. DevMed Child Neurol. 1988;30:711-722.
9. Pinto-Martin JA, Riolo S, Cnaan A, et al. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics. 1995;95249-254.
10. Aziz K, Vickar DB, Sauve RS, et al. Provincebased study of neurologic disability of children weighing 500 through 1249 grams at birth in relation to neonatal cerebral ultrasound findings. Pediatrics. 1995;95:837-844.
11. van de Bor M, Verloove-Vanhorick SP, Brand R, et al. Incidence and prediction of periventricularintraventricular hemorrhage in very preterm infants. J Perinat Med. 1987;15:333-339.
12. Kuban KCK, Leviton A, Pagano M, et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neural. 1992;7:70-76.
13. O'Shea M, Savitz DA, Hage ML, Feinstein KA. Prenatal events and the risk of subependymalAntraventricular haemorrhage in very low birthweight neonates. Paediatr Perinat Epidemiol. 1992;6:352-362.
14. American College of Obstetricians and Gynecologists. Management of Preeclampsia. Washington, DC: American College of Obstetricians and Gynecologists; 1986. Technical bulletin 91.
15. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 1995;90:263-269.
16. Hauth JC, Goldenberg RL, Nelson KG, et al. Reduction of cerebral palsy with maternal MgSO4 treatment in newborns weighing 500-1000 g. Am J Obstet Gynecol. 1993;172(1, pt 2):419. Abstract.
17. Berg CJ, Zupan J, d'Almada PJ, et al. Gestational age and intrauterine growth retardation among white and black very low birthweight infants. Paediatr Perinat Epidemiol. 1994;8:53-61.
18. Boyle ÇA, Yeargin-Allsopp M, Doernberg N, et al. Prevalence of selected developmental disabilities in children aged 3-10 years. MMWR CDC Serveill Summ. 1996;45(SS-2):1-14.
19. Mutch L, Alberman E, Hagberg B, et al. Cerebral palsy epidemiology. Dev Ued Child Neurol. 1992;34:547-551.
20. Wilcosky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985;38:849-856.
21. Flanders WD, Rhodes PH. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. J Chronic Dis. 1987;40:697-704.
22. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. New York, N Y: Van Nostrand Reinhold Co; 1982.
23. Groome LJ, Goldenberg RL, Cliver SP, et al, and the March of Dimes Multicenter Study Group. Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am J Obstet Gynecol. 1992;167:873-879.
24. Leviton A, Kuban KG, Pagano M, et al. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics. 1993;91:1083-1088.
25. Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome in a randomized double-blindcontrolled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96:38-43.
26. Johnston MM, Sanchez-Ramos L, Vaughn AJ, et al. Antibiotic therapy in preterm premature rupture of membranes. Am J Obstet Gynecol. 1990; 163:743-747.
27. Scottish Low Birthweight Study Group. The Scottish Low Birthweight Study, I. Arch Dis Child. 1992;67:675-686.
28. Weisglas-Kuperus N, Baerts W, Snirkovsky M, Sauer PJJ. Effects of biological and social factors on the cognitive development of very low birth weight children. Pediatrics. 1993;92:658-665.
29. Ens-Dokkum MH, Johnson A, Schrueder AM, et al. Comparison of mortality and rates of cerebral palsy in two populations of very low birth-weight infants. Arch Dis Child. 1994;70(suppl 2): F96-F100.
30. Blair E, Palmer L, Stanley F. Cerebral palsy in very low birthweight infants, pre-eclampsia and magnesium sulfate. Pediatrics. 1996;97:780-781.
31. Johnson MA, Cox M, McKim E. Outcome of infants of very low birthweight: a geographically based study. Can Med Assoc J. 1987;136:1157-1165.
32. Scottish Low Birthweight Study Group. The Scottish Low Birthweight Study, II. Arch Dis Child. 1992;67:682-686.
33. Volpe JJ. Neurology of the Newborn. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1995.
34. McDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990;109:234-238.
35. Huffman DJ, Marro PJ, McGowan JE, et al. Protective effect of MgS04 infusion on NMDA receptor binding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res. 1994;644:144-149.
36. Marret S, Gressens P, Gadisseux J-F, Evrard P. Prevention by magnesium of excitotoxic neuronal death in the developing brain. Dev Med Child Neural 1995;37:473-484.